Potentiation of photic circadian clock phase shifts

光生物钟相移的增强

基本信息

  • 批准号:
    7454623
  • 负责人:
  • 金额:
    $ 0.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-05-01 至 2008-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Arousal and sleep deprivation can regulate circadian rhythms in multiple ways. One extremely important effect is the ability of these non-photic, higher level inputs to antagonize the synchronizing effects of light, as shown, for example, in studies where non-photic stimuli can block photic phase shift responses. We recently discovered that blocking the non-photic neuropeptide Y (NPY) input pathway to the suprachiasmatic nuclei (SCN) can potentiate photic phase shifting, suggesting that this pathway tonically suppresses the effects of light, and pharmacological treatments can release the animal from these inhibitory effects. We know that non-photic inputs to the circadian clock are represented by both NPY and serotonergic pathways. Remarkably, blocking both NPY and serotonergic inputs potentiates photic effects to an even greater degree, such that a 5 min light pulse is able to induce a 7 h phase shift of circadian rhythms of a treated hamster, as compared to a circa-1 h phase shift in an untreated hamster. This grant will build upon these findings of greatly potentiated light-induced phase shifts when the arousal-related NPY and serotonergic inputs are pharmacologically blocked. We will test these hypotheses: Hypothesis 1: NPY Y5 and serotonin 5HT1A receptors regulate the phase shifting effects of light at multiple phases throughout the subjective night. Hypothesis 2: Non-input inputs do not need to coincide with light, but can alter the response to light when presented within 1 h of light onset or offset. Hypothesis 3: NPY and 5HT inputs alter light-induction of per1 and per2 gene expression. The capability of NPY and serotonin antagonists to potentiate and agonists to attenuate the effects of light on the circadian system could be a potentially useful tool in clinical research. In cases of entrainment disorders, such as delayed or advanced sleep phase syndrome, potentiating the effects of light at one time while blocking effects of light at another phase might be an approach to correct the phase of entrainment. Symptoms of jet lag might be shortened in duration if resetting effects of light in the new time zone are potentiated. Shift workers might benefit from blocking the effects of light at night. The progress of cancer is slower in patients with enhanced circadian rhythmicity, a benefit that might accrue from better circadian entrainment
描述(由申请人提供):唤醒和睡眠剥夺可以通过多种方式调节昼夜节律。一个极其重要的效应是这些非光的、更高水平的输入对抗光的同步效应的能力,例如,如在非光刺激可以阻断光相移响应的研究中所示。我们最近发现,阻断非光神经肽Y(NPY)输入途径的视交叉上核(SCN)可以增强光相移,这表明该途径紧张性抑制光的作用,药物治疗可以释放这些抑制作用的动物。我们知道,非光输入的昼夜节律钟是由神经肽Y和β-肾上腺素能途径。值得注意的是,阻断神经肽Y和血清素能输入会更大程度地增强光效应,因此5分钟的光脉冲能够诱导治疗仓鼠的昼夜节律发生7小时的相移,而未治疗仓鼠的昼夜节律发生约1小时的相移。这项拨款将建立在这些发现的基础上,即当觉醒相关的NPY和多巴胺能输入被阻断时,光诱导的相移大大增强。我们将测试这些假设:假设1:NPY Y 5和5-羟色胺5 HT 1A受体在整个主观夜晚的多个阶段调节光的相移效应。假设二:非输入输入不需要与光一致,但可以在光开始或偏移的1小时内呈现时改变对光的响应。假设3:NPY和5 HT输入改变了per 1和per 2基因表达的光诱导。 NPY和5-羟色胺拮抗剂增强和激动剂减弱光对昼夜节律系统的影响的能力可能是临床研究中潜在有用的工具。在夹带障碍的情况下,例如延迟或提前睡眠阶段综合征,在一个时间增强光的影响,同时在另一个阶段阻断光的影响可能是纠正夹带阶段的方法。如果在新的时区光线的重置效果得到加强,时差综合征的症状可能会缩短。轮班工作者可能会受益于在夜间阻挡光线的影响。昼夜节律性增强的患者癌症进展较慢,这可能是由于更好的昼夜节律夹带而产生的益处

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Neuropeptide Y-deficient mice show altered circadian response to simulated natural photoperiod.
  • DOI:
    10.1016/j.brainres.2008.09.040
  • 发表时间:
    2008-12-30
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Kim HJ;Harrington ME
  • 通讯作者:
    Harrington ME
NAN-190 potentiates the circadian response to light and speeds re-entrainment to advanced light cycles.
NAN-190 增强对光的昼夜节律反应,并加速重新进入高级光周期。
  • DOI:
    10.1016/j.neuroscience.2008.04.054
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Kessler,EJ;Sprouse,J;Harrington,ME
  • 通讯作者:
    Harrington,ME
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY E HARRINGTON其他文献

MARY E HARRINGTON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY E HARRINGTON', 18)}}的其他基金

Developing Training Materials for Experimental Rigor in Neuroscience
开发神经科学实验严谨性的培训材料
  • 批准号:
    10512955
  • 财政年份:
    2022
  • 资助金额:
    $ 0.93万
  • 项目类别:
Developing Training Materials for Experimental Rigor in Neuroscience
开发神经科学实验严谨性的培训材料
  • 批准号:
    10665056
  • 财政年份:
    2022
  • 资助金额:
    $ 0.93万
  • 项目类别:
In vivo tracking of bioluminescent markers of circadian rhythms in behaving animals
行为动物昼夜节律生物发光标记的体内追踪
  • 批准号:
    10730688
  • 财政年份:
    2017
  • 资助金额:
    $ 0.93万
  • 项目类别:
Building foundations for a neurobiology of fatigue: validating an animal model
为疲劳神经生物学奠定基础:验证动物模型
  • 批准号:
    8427275
  • 财政年份:
    2012
  • 资助金额:
    $ 0.93万
  • 项目类别:
Building foundations for a neurobiology of fatigue: validating an animal model
为疲劳神经生物学奠定基础:验证动物模型
  • 批准号:
    8242265
  • 财政年份:
    2012
  • 资助金额:
    $ 0.93万
  • 项目类别:
Circadian clock suppression in cancer-related fatigue
癌症相关疲劳中的昼夜节律抑制
  • 批准号:
    7386126
  • 财政年份:
    2008
  • 资助金额:
    $ 0.93万
  • 项目类别:
Circadian clock suppression in cancer-related fatigue
癌症相关疲劳中的昼夜节律抑制
  • 批准号:
    7595251
  • 财政年份:
    2008
  • 资助金额:
    $ 0.93万
  • 项目类别:
Potentiation of photic circadian clock phase shifts
光生物钟相移的增强
  • 批准号:
    7075789
  • 财政年份:
    2006
  • 资助金额:
    $ 0.93万
  • 项目类别:
NEURAL BASIS OF BIOLOGICAL RHYTHMS
生物节律的神经基础
  • 批准号:
    2259646
  • 财政年份:
    1994
  • 资助金额:
    $ 0.93万
  • 项目类别:
NEURAL BASIS OF BIOLOGICAL RHYTHMS
生物节律的神经基础
  • 批准号:
    2460448
  • 财政年份:
    1994
  • 资助金额:
    $ 0.93万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 0.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 0.93万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 0.93万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 0.93万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 0.93万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 0.93万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 0.93万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 0.93万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 0.93万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 0.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了